Latest Insider Transactions at Intercept Pharmaceuticals, Inc. (ICPT)
This section provides a real-time view of insider transactions for Intercept Pharmaceuticals, Inc. (ICPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTERCEPT PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTERCEPT PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2023
|
Srinivas Akkaraju Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,111
-100.0%
|
$154,109
$19.0 P/Share
|
|
Nov 08
2023
|
Srinivas Akkaraju Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
640,688
-100.0%
|
$12,173,072
$19.0 P/Share
|
|
Nov 08
2023
|
Srinivas Akkaraju Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
37,887
-100.0%
|
$719,853
$19.0 P/Share
|
|
Nov 08
2023
|
Nancy Miller Rich Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,111
-100.0%
|
$154,109
$19.0 P/Share
|
|
Nov 08
2023
|
Nancy Miller Rich Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
22,304
-100.0%
|
$423,776
$19.0 P/Share
|
|
Nov 08
2023
|
Gino Santini Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,111
-100.0%
|
$154,109
$19.0 P/Share
|
|
Nov 08
2023
|
Gino Santini Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
23,645
-100.0%
|
$449,255
$19.0 P/Share
|
|
Nov 08
2023
|
Glenn Sblendorio Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,111
-100.0%
|
$154,109
$19.0 P/Share
|
|
Nov 08
2023
|
Glenn Sblendorio Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
23,447
-100.0%
|
$445,493
$19.0 P/Share
|
|
Nov 08
2023
|
Luca Benatti Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,111
-100.0%
|
$154,109
$19.0 P/Share
|
|
Nov 08
2023
|
Luca Benatti Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
25,487
-100.0%
|
$484,253
$19.0 P/Share
|
|
Nov 08
2023
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,585
-100.0%
|
$505,115
$19.0 P/Share
|
|
Nov 08
2023
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
16,706
-100.0%
|
$317,414
$19.0 P/Share
|
|
Nov 08
2023
|
Fundaro Paolo Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,111
-100.0%
|
$154,109
$19.0 P/Share
|
|
Nov 08
2023
|
Fundaro Paolo Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
35,794
-100.0%
|
$680,086
$19.0 P/Share
|
|
Nov 08
2023
|
M Michelle Berrey President, R&D and CMO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
51,790
-100.0%
|
$984,010
$19.0 P/Share
|
|
Nov 08
2023
|
M Michelle Berrey President, R&D and CMO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
28,349
-100.0%
|
$538,631
$19.0 P/Share
|
|
Nov 08
2023
|
Rocco Venezia Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,669
-100.0%
|
$278,711
$19.0 P/Share
|
|
Nov 08
2023
|
Rocco Venezia Chief Accounting Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
10,782
-100.0%
|
$204,858
$19.0 P/Share
|
|
Nov 08
2023
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
45,244
-100.0%
|
$859,636
$19.0 P/Share
|
|
Nov 08
2023
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
23,021
-100.0%
|
$437,399
$19.0 P/Share
|
|
Nov 08
2023
|
Mark Pruzanski Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
618,894
-100.0%
|
$11,758,986
$19.0 P/Share
|
|
Nov 08
2023
|
Jerome Benedict Durso CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
102,825
-100.0%
|
$1,953,675
$19.0 P/Share
|
|
Nov 08
2023
|
Jerome Benedict Durso CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
51,815
-100.0%
|
$984,485
$19.0 P/Share
|
|
Nov 08
2023
|
Daniel Bradbury Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,111
-100.0%
|
$154,109
$19.0 P/Share
|
|
Nov 08
2023
|
Daniel Bradbury Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
7,812
-100.0%
|
$148,428
$19.0 P/Share
|
|
Nov 08
2023
|
Daniel Bradbury Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
23,548
-100.0%
|
$447,412
$19.0 P/Share
|
|
Nov 08
2023
|
Jared Freedberg General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,762
-100.0%
|
$641,478
$19.0 P/Share
|
|
Nov 08
2023
|
Jared Freedberg General Counsel |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
22,681
-100.0%
|
$430,939
$19.0 P/Share
|
|
Nov 08
2023
|
David A Ford Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,400
-100.0%
|
$406,600
$19.0 P/Share
|
|
Nov 08
2023
|
David A Ford Chief Human Resources Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,038
-100.0%
|
$285,722
$19.0 P/Share
|
|
Nov 08
2023
|
Keith Michael Gottesdiener Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,111
-100.0%
|
$154,109
$19.0 P/Share
|
|
Nov 08
2023
|
Keith Michael Gottesdiener Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
24,719
-100.0%
|
$469,661
$19.0 P/Share
|
|
Nov 08
2023
|
Dagmar Rosa Bjorkeson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,625
-100.0%
|
$220,875
$19.0 P/Share
|
|
Nov 08
2023
|
Dagmar Rosa Bjorkeson Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
14,766
-100.0%
|
$280,554
$19.0 P/Share
|
|
Nov 01
2023
|
Jared Freedberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
771
-1.35%
|
$13,878
$18.96 P/Share
|
|
Sep 21
2023
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
908
-1.31%
|
$9,080
$10.8 P/Share
|
|
Sep 14
2023
|
M Michelle Berrey President, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-1.53%
|
$13,706
$11.57 P/Share
|
|
Aug 01
2023
|
Jared Freedberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
771
-1.33%
|
$7,710
$10.5 P/Share
|
|
Jun 21
2023
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
908
-1.3%
|
$9,988
$11.74 P/Share
|
|
Jun 14
2023
|
M Michelle Berrey President, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-1.51%
|
$14,952
$12.04 P/Share
|
|
May 24
2023
|
Fundaro Paolo Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+15.59%
|
-
|
|
May 24
2023
|
Keith Michael Gottesdiener Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+19.81%
|
-
|
|
May 24
2023
|
Glenn Sblendorio Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+20.45%
|
-
|
|
May 24
2023
|
Luca Benatti Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+19.45%
|
-
|
|
May 24
2023
|
Srinivas Akkaraju Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+14.99%
|
-
|
|
May 24
2023
|
Daniel Bradbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+20.39%
|
-
|
|
May 24
2023
|
Nancy Miller Rich Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+21.05%
|
-
|
|
May 24
2023
|
Dagmar Rosa Bjorkeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+23.51%
|
-
|
|
May 24
2023
|
Gino Santini Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+20.35%
|
-
|